This study is currently not recruiting participants.

CC100: Safety and Tolerability of Single Doses

Study on Safety and Tolerance of an Investigational Oral Medication

Not Recruiting
18 years - 65 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to see if CC100, given by mouth, is safe and is tolerated in increasing doses.

Detailed description of study

The purpose of this study is to see if CC100, given by mouth, is safe and is tolerated in increasing doses.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Drug Safety
  • Age: 18 years - 65 years
  • Gender: All

This study investigates the safety and tolerance of an investigational oral medication, referred to as CC100, when administered in increasing doses. The study aims to understand how the investigational medication is processed by the body and whether it is safe to use.

Participants in the study will take the investigational medication by mouth, with doses gradually increasing. The study will monitor participants for any side effects or reactions to ensure that the medication is tolerated well.

  • Who can participate: Adults aged 18-65 years who are in good health and meet specific inclusion criteria.
  • Study details: Participants will take the investigational medication orally, and the doses will be increased gradually. Researchers will observe for any side effects to assess safety and tolerance.
Updated on 19 Feb 2024. Study ID: 1303010927

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team